Literature DB >> 34249745

Computer-Aided Diagnosis Evaluation of the Correlation Between Magnetic Resonance Imaging With Molecular Subtypes in Breast Cancer.

Wei Meng1, Yunfeng Sun1, Haibin Qian1, Xiaodan Chen2, Qiujie Yu1, Nanding Abiyasi3, Shaolei Yan1, Haiyong Peng1, Hongxia Zhang1, Xiushi Zhang1.   

Abstract

BACKGROUND: There is a demand for additional alternative methods that can allow the differentiation of the breast tumor into molecular subtypes precisely and conveniently.
PURPOSE: The present study aimed to determine suitable optimal classifiers and investigate the general applicability of computer-aided diagnosis (CAD) to associate between the breast cancer molecular subtype and the extracted MR imaging features.
METHODS: We analyzed a total of 264 patients (mean age: 47.9 ± 9.7 years; range: 19-81 years) with 264 masses (mean size: 28.6 ± 15.86 mm; range: 5-91 mm) using a Unet model and Gradient Tree Boosting for segmentation and classification.
RESULTS: The tumors were segmented clearly by the Unet model automatically. All the extracted features which including the shape features,the texture features of the tumors and the clinical features were input into the classifiers for classification, and the results showed that the GTB classifier is superior to other classifiers, which achieved F1-Score 0.72, AUC 0.81 and score 0.71. Analyzed the different features combinations, we founded that the texture features associated with the clinical features are the optimal features to different the breast cancer subtypes.
CONCLUSION: CAD is feasible to differentiate the breast cancer subtypes, automatical segmentation were feasible by Unet model and the extracted texture features from breast MR imaging with the clinical features can be used to help differentiating the molecular subtype. Moreover, in the clinical features, BPE and age characteristics have the best potential for subtype.
Copyright © 2021 Meng, Sun, Qian, Chen, Yu, Abiyasi, Yan, Peng, Zhang and Zhang.

Entities:  

Keywords:  breast cancer; computer-aided diagnosis; gradient tree boosting; magnetic resonance imaging; molecular subtypes

Year:  2021        PMID: 34249745      PMCID: PMC8260834          DOI: 10.3389/fonc.2021.693339

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  23 in total

1.  Recurrent residual U-Net for medical image segmentation.

Authors:  Md Zahangir Alom; Chris Yakopcic; Mahmudul Hasan; Tarek M Taha; Vijayan K Asari
Journal:  J Med Imaging (Bellingham)       Date:  2019-03-27

2.  Detection and characterization of MRI breast lesions using deep learning.

Authors:  P Herent; B Schmauch; P Jehanno; O Dehaene; C Saillard; C Balleyguier; J Arfi-Rouche; S Jégou
Journal:  Diagn Interv Imaging       Date:  2019-03-26       Impact factor: 4.026

3.  Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.

Authors:  Giuseppe Dilorenzo; Michele Telegrafo; Daniele La Forgia; Amato Antonio Stabile Ianora; Marco Moschetta
Journal:  Eur J Radiol       Date:  2019-02-15       Impact factor: 3.528

4.  Newly Diagnosed Breast Cancer: Comparison of Contrast-enhanced Spectral Mammography and Breast MR Imaging in the Evaluation of Extent of Disease.

Authors:  Stephanie A Lee-Felker; Leena Tekchandani; Mariam Thomas; Esha Gupta; Denise Andrews-Tang; Antoinette Roth; James Sayre; Guita Rahbar
Journal:  Radiology       Date:  2017-06-26       Impact factor: 11.105

5.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

6.  Accuracy of mammography, digital breast tomosynthesis, ultrasound and MR imaging in preoperative assessment of breast cancer.

Authors:  Giovanna Mariscotti; Nehmat Houssami; Manuela Durando; Laura Bergamasco; Pier Paolo Campanino; Chiara Ruggieri; Elisa Regini; Andrea Luparia; Riccardo Bussone; Anna Sapino; Paolo Fonio; Giovanni Gandini
Journal:  Anticancer Res       Date:  2014-03       Impact factor: 2.480

7.  Machine Learning-Based Analysis of MR Multiparametric Radiomics for the Subtype Classification of Breast Cancer.

Authors:  Tianwen Xie; Zhe Wang; Qiufeng Zhao; Qianming Bai; Xiaoyan Zhou; Yajia Gu; Weijun Peng; He Wang
Journal:  Front Oncol       Date:  2019-06-14       Impact factor: 6.244

8.  Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.

Authors:  Joao V Horvat; Blanca Bernard-Davila; Thomas H Helbich; Michelle Zhang; Elizabeth A Morris; Sunitha B Thakur; R Elena Ochoa-Albiztegui; Doris Leithner; Maria A Marino; Pascal A Baltzer; Paola Clauser; Panagiotis Kapetas; Zsuzsanna Bago-Horvath; Katja Pinker
Journal:  J Magn Reson Imaging       Date:  2019-02-27       Impact factor: 4.813

9.  Evaluating the Accuracy of Breast Cancer and Molecular Subtype Diagnosis by Ultrasound Image Deep Learning Model.

Authors:  Xianyu Zhang; Hui Li; Chaoyun Wang; Wen Cheng; Yuntao Zhu; Dapeng Li; Hui Jing; Shu Li; Jiahui Hou; Jiaying Li; Yingpu Li; Yashuang Zhao; Hongwei Mo; Da Pang
Journal:  Front Oncol       Date:  2021-03-05       Impact factor: 6.244

10.  Non-Invasive Assessment of Breast Cancer Molecular Subtypes with Multiparametric Magnetic Resonance Imaging Radiomics.

Authors:  Doris Leithner; Marius E Mayerhoefer; Danny F Martinez; Maxine S Jochelson; Elizabeth A Morris; Sunitha B Thakur; Katja Pinker
Journal:  J Clin Med       Date:  2020-06-14       Impact factor: 4.241

View more
  1 in total

1.  Breast Cancer Classification on Multiparametric MRI - Increased Performance of Boosting Ensemble Methods.

Authors:  Alexandros Vamvakas; Dimitra Tsivaka; Andreas Logothetis; Katerina Vassiou; Ioannis Tsougos
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.